Efficacy and safety of tralokinumab monotherapy in North American adult patients with moderate-to-severe atopic dermatitis: A subanalysis of the ECZTRA 2 trial

被引：0
|
作者：
Wiseman, Marni [1 ,2 ,3 ]
Armstrong, April W. [4 ]
Soung, Jennifer [5 ,6 ]
Albrecht, Lorne [3 ,7 ]
Lomaga, Mark [3 ,8 ]
Papp, Kim A. [3 ,9 ]
机构：
[1] Univ Manitoba, Dept Med, Winnipeg, MB, Canada
[2] Univ Manitoba, Dept Dermatol, Winnipeg, MB, Canada
[3] Prob Med Res, Waterloo, ON, Canada
[4] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90007 USA
[5] Southern Calif Dermatol, Santa Ana, CA USA
[6] Harbor Univ Calif Los Angeles, Los Angeles, CA USA
[7] Enverus Med Res, Surrey, BC, Canada
[8] DermEdge Res, Mississauga, ON, Canada
[9] K Papp Clin Res, Waterloo, ON, Canada
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
28186
引用
收藏
页码：AB178 / AB178
页数：1
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF TRALOKINUMAB IN A KOREAN SUBPOPULATION OF PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: A SUBANALYSIS OF ECZTRA 2, A PHASE 3, MONOTHERAPY, RANDOMIZED, DOUBLEBLIND, PLACEBO-CONTROLLED TRIAL
    Kim, Kyu Han
    Son, Sang Wook
    Lee, Yang Won
    Simpson, Eric L.
    Kuznetsova, Alexandra
    Cho, Sang Hyun
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 63 - 63
  • [2] Tralokinumab Efficacy and Safety, with or without Topical Corticosteroids, in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of Phase 3 Trials ECZTRA 1, 2, and 3
    Blauvelt, Andrew
    Gooderham, Melinda
    Bhatia, Neal
    Langley, Richard G.
    Schneider, Shannon
    Zoidis, John
    Kurbasic, Azra
    Armstrong, April
    Silverberg, Jonathan, I
    DERMATOLOGY AND THERAPY, 2022, 12 (11) : 2499 - 2516
  • [3] Tralokinumab Efficacy and Safety, with or without Topical Corticosteroids, in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of Phase 3 Trials ECZTRA 1, 2, and 3
    Andrew Blauvelt
    Melinda Gooderham
    Neal Bhatia
    Richard G. Langley
    Shannon Schneider
    John Zoidis
    Azra Kurbasic
    April Armstrong
    Jonathan I. Silverberg
    Dermatology and Therapy, 2022, 12 : 2499 - 2516
  • [4] Efficacy and safety of tralokinumab in adolescents with moderate-to-severe atopic dermatitis: results of the phase III ECZTRA 6 trial
    Paller, Amy
    Blauvelt, Andrew
    Soong, Weily
    Imafuku, Shinichi
    Hong, Chih-Ho
    Schuttelaar, Marie L. A.
    Amoudruz, Petra
    Kurbasic, Azra
    Soldbro, Lise
    Lophaven, Katja
    Cork, Michael
    Bewley, Anthony
    Simpson, Eric L.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E90 - E91
  • [5] Efficacy and safety of tralokinumab in adolescents with moderate-to-severe atopic dermatitis: results of the phase III ECZTRA 6 trial
    Paller, A.
    Blauvelt, A.
    Soong, W.
    Imafuku, S.
    Hong, C.
    Schuttelaar, M. L. A.
    Amoudruz, P.
    Kurbasic, A.
    Soldbro, L.
    Lophaven, K.
    Schneider, S.
    Cork, M.
    Bewley, A.
    Simpson, E. L.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E145 - E146
  • [6] Safety and Efficacy of Tralokinumab in Older Adults With Moderate-to-Severe Atopic Dermatitis
    Merola, Joseph F.
    Butler, Daniel C.
    Mark, Thomas
    Schneider, Shannon
    Kim, Yestle
    Abuabara, Katrina
    JAMA DERMATOLOGY, 2023, 159 (10) : 1119 - 1123
  • [7] Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis The Phase 3 ECZTRA 6 Randomized Clinical Trial
    Paller, Amy S.
    Flohr, Carsten
    Cork, Michael
    Bewley, Anthony
    Blauvelt, Andrew
    Hong, H. Chih-ho
    Imafuku, Shinichi
    Schuttelaar, Marie L. A.
    Simpson, Eric L.
    Soong, Weily
    Arlert, Petra
    Lophaven, Katja Wendicke
    Kurbasic, Azra
    Soldbro, Lise
    Vest, Natacha Strange
    Wollenberg, Andreas
    JAMA DERMATOLOGY, 2023, 159 (06) : 596 - 605
  • [8] Tralokinumab provides progressive and sustained efficacy in adolescents with moderate-to-severe atopic dermatitis: a post-hoc analysis of the ECZTRA 6 trial
    Simpson, Eric L.
    Wollenberg, Andreas
    Kurbasic, Azra
    Tindberg, Ann-Marie
    Soldbro, Lise
    Paller, Amy S.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [9] USE OF TOPICAL CORTICOSTEROIDS WITH TRALOKINUMAB IN ADULT PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: RESULTS FROM THE 32-WEEK, PHASE 3 ECZTRA 3 TRIAL
    Silverberg, Jonathan I.
    Pink, Andrew E.
    Kurbasic, Azra
    Olsen, Christina Kurre
    Weidinger, Stephan
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 55 - 55
  • [10] Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis A Randomized Clinical Trial
    Silverberg, Jonathan, I
    Simpson, Eric L.
    Thyssen, Jacob P.
    Gooderham, Melinda
    Chan, Gary
    Feeney, Claire
    Biswas, Pinaki
    Valdez, Hernan
    DiBonaventura, Marco
    Nduaka, Chudy
    Rojo, Ricardo
    JAMA DERMATOLOGY, 2020, 156 (08) : 863 - 873
12345